Florence L. Kelm-Calvez - Publications

TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.

Journal: International journal of molecular sciences

Published: August 11, 2022

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.

Journal: Cancers

Published: October 23, 2020

Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: October 02, 2020

Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.

Journal: International journal of molecular sciences

Published: July 31, 2020

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.

Journal: EBioMedicine

Published: December 05, 2019

Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.

Journal: NAR genomics and bioinformatics

Published: June 06, 2019

Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches.

Journal: Oncotarget

Published: April 27, 2017

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.

Journal: Genetics and molecular biology

Published: December 12, 2014